Q2 2019

Source filing unavailable

Q2 2019 · —

Revenue

€4.35B

+3.1% vs Q2 2018

Net Income

€253.78M

−74.5% vs Q2 2018

EPS Diluted

€0.84

−74.0% vs Q2 2018

Gross Profit€1,330,922,000+2.0%

Operating Income€521,257,000−62.8%

Operating Cash Flowderived

Same quarter

Metric	Q2 2019	Q2 2018	Q2 2017
Revenue	€4.35B	€4.21B	€4.47B
Net Income	€253.78M	€993.98M	€268.69M
EPS Diluted	€0.84	€3.23	€0.87

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Fresenius Medical Care AG · CIK 1333141 · Engraved from SEC EDGAR